These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma. Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430 [TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808 [TBL] [Abstract][Full Text] [Related]
5. [Progress of research on pressurized metered dose inhalers]. Zhou X Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147 [No Abstract] [Full Text] [Related]
6. Extra fine hydrofluoroalkane-134A beclomethasone aerosols: selecting an optimal inhaled steroid for an individual patient. Dean NL Chest; 1999 Sep; 116(3):841-2. PubMed ID: 10492300 [No Abstract] [Full Text] [Related]
7. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a. Steckel H; Müller BW Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025 [TBL] [Abstract][Full Text] [Related]
8. Influence of respiratory spacer devices on aerodynamic particle size distribution and fine particle mass of beclomethasone from metered-dose inhalers. Feddah MR; Davies NM; Gipps EM; Brown KF J Aerosol Med; 2001; 14(4):477-85. PubMed ID: 11791688 [TBL] [Abstract][Full Text] [Related]
9. Aerosol characterization of three corticosteroid metered dose inhalers with volumatic holding chambers and metered dose inhalers alone at two inspiratory flow rates. Terzano C; Mannino F J Aerosol Med; 1999; 12(4):249-54. PubMed ID: 10724639 [TBL] [Abstract][Full Text] [Related]
10. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients. Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204 [TBL] [Abstract][Full Text] [Related]
11. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children]. Yoshida Y; Inoue T; Nishikido T; Kameda M; Takamatu I; Doi S Arerugi; 2007 Dec; 56(12):1502-9. PubMed ID: 18195554 [TBL] [Abstract][Full Text] [Related]
12. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study. Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114 [TBL] [Abstract][Full Text] [Related]
13. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. Wolthers OD; Walters EG Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529 [TBL] [Abstract][Full Text] [Related]
14. Modulation of aerosol clouds produced by pressurised inhalation aerosols. Brambilla G; Ganderton D; Garzia R; Lewis D; Meakin B; Ventura P Int J Pharm; 1999 Sep; 186(1):53-61. PubMed ID: 10469923 [TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Cripps A; Riebe M; Schulze M; Woodhouse R Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679 [TBL] [Abstract][Full Text] [Related]
16. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a. Wolthers OD Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590 [TBL] [Abstract][Full Text] [Related]